login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
VERTEX PHARMACEUTICALS INC (VRTX) Stock News
USA
- NASDAQ:VRTX -
US92532F1003
-
Common Stock
419.51
USD
-0.66 (-0.16%)
Last: 10/28/2025, 12:51:32 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
VRTX Latest News, Press Relases and Analysis
All
Press Releases
8 days ago - By: Chartmill
Vertex Pharmaceuticals Inc (NASDAQ:VRTX): A Value Investment Case Study
13 days ago - By: Chartmill
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Offers Affordable Growth in Biotech
3 hours ago - By: The Motley Fool
- Mentions:
NVO
LLY
If I Could Only Buy 2 Stocks in the Last Quarter of 2025, I'd Pick These
21 hours ago - By: Vertex Pharmaceuticals Incorporated
Vertex to Participate in the UBS Global Healthcare Conference on November 11
a day ago - By: Zacks Investment Research
- Mentions:
ANIP
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
a day ago - By: The Motley Fool
- Mentions:
PFE
Prediction: Vertex Pharmaceuticals Will Be Worth More Than Pfizer by 2030
4 days ago - By: Zacks Investment Research
- Mentions:
MA
NFLX
C
ADI
...
Top Stock Reports for Mastercard, Netflix & Citigroup
5 days ago - By: Vertex Pharmaceuticals Incorporated
Vertex Presents New Data Across Portfolio of Cystic Fibrosis Medicines Including ALYFTREK® at the North American Cystic Fibrosis Conference
11 days ago - By: Zacks Investment Research
Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know
11 days ago - By: Vertex Pharmaceuticals Incorporated
Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week
14 days ago - By: Benzinga
Here's How Much $100 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today
20 days ago - By: Benzinga
Spotlight on Vertex Pharmaceuticals: Analyzing the Surge in Options Activity
22 days ago - By: Vertex Pharmaceuticals Incorporated
Vertex to Announce Third Quarter 2025 Financial Results on November 3rd
26 days ago - By: Zacks Investment Research
Vertex Pharmaceuticals (VRTX) Exceeds Market Returns: Some Facts to Consider
a month ago - By: Investor's Business Daily
- Mentions:
XPH
PPH
XBI
IBB
...
Pharma Tariffs Back In Spotlight On New Trump Threat
a month ago - By: Vertex Pharmaceuticals Incorporated
Vertex Announces Key Advancements Across Kidney Portfolio
Please enable JavaScript to continue using this application.